Dublin, Aug. 29, 2024 (GLOBE NEWSWIRE) -- The "Contract Pharmaceutical Manufacturing, Research, and Packaging Market Forecasts to 2029" report has been added to ResearchAndMarkets.com's offering.
The global market for contract pharmaceutical manufacturing, research and packaging is estimated to increase from $212.2 billion in 2023 to reach $310.2 billion by 2029, at a compound annual growth rate (CAGR) of 6.7% from 2024 through 2029.
Contract manufacturers currently play central roles in pharmaceutical manufacturing. Fierce competition, stringent regulations, patent expirations and pressure to reduce drug development and manufacturing costs drive the pharmaceutical outsourcing market. The roles of outsourcing partners have evolved from mere auxiliary support to leaders of innovation.
Large bio/pharma companies contribute the majority share of the contract development and manufacturing organization (CDMO) market due to commercial manufacturing activity. Small biotech companies account for a larger share of the molecule pipeline, incorporating outsourcing into their business models to conserve capital resources and expedite speed to market.
The contract manufacturing services market for contract pharmaceutical manufacturing, research and packaging is estimated to increase from $123.6 billion in 2023 to reach $183.3 billion by 2029, at a CAGR of 7% from 2024 through 2029.
Strict regulatory environments are making the drug development process an increasingly difficult task. Technological challenges force drug developers to think creatively regarding innovations and business models. The pharmaceutical industry collaborates with different outsourcing providers throughout the research and development cycle of new products to meet these challenges.
The contract research services market for contract pharmaceutical manufacturing, research, and packaging is estimated to increase from $72.4 billion in 2023 to reach $104.1 billion by 2029, at a CAGR of 6.3% from 2024 through 2029.
The pharmaceutical contract packaging industry is directly related to the demand and sales of pharmaceutical products. The growing pharmaceuticals market, the demand for advanced packaging solutions, the need for specialized packaging equipment and expertise, along with regulatory compliance and cost efficiency drive the pharmaceutical contract manufacturing market. The demand for timely commercial packaging services for low-volume drugs (e.g., niche, orphan products) is also increasing.
This report provides in-depth knowledge of the global pharmaceutical contract manufacturing, research, and packaging market, both in terms of qualitative and quantitative data, to help readers develop and assess the market landscape business/growth strategies, analyze their market position in the current marketplace, and make informed business decisions regarding pharmaceutical contract manufacturing, research, and packaging. The report estimates market size data for 2023 (the base year) and forecasts values for 2024 through 2029.
The contract manufacturing segment is analyzed by product type, dosage form, drug molecule type, drug delivery technologies, and region. The contract research market is analyzed based on discovery, preclinical, and clinical research functional services.
The contract packaging market covers primary, secondary, and tertiary packaging. Primary packaging are categorized as bottles and vials, blisters, and others (e.g., prefilled-syringes, inhalers, caps and closures, dosing droppers, labels, and accessories) to analyze the primary packaging market.
Industry growth trends, drivers, restraints, and opportunities in the pharmaceutical contract manufacturing, research, and packaging market are also discussed in detail. The scope of the study is global. The report analyzes each market and its application, new products and advancements, market projections, and market shares.
The report includes:
- 67 data tables and 41 additional tables
- Analysis of the global markets for pharmaceutical and biopharmaceutical contract manufacturing, research and packaging services
- Analyses of global market trends, with market revenue data from 2022 to 2023, estimates for 2024, forecasts for 2025, and projected CAGRs through 2029
- Estimate of the current market size and revenue prospects of the global market, along with a market share analysis by drug type, dosage form, formulation type, application, and region
- Facts and figures pertaining to the market dynamics, current and emerging technologies, regulations, and the expected impact of macroeconomic factors
- Review of the industry supply chain, using the Porter's Five Forces and PESTLE models, to analyze the prevailing micro- and macro environmental factors
- Overview of ESG developments and sustainability trends in the industry, with a focus on consumer attitudes, companies' ESG score rankings and their ESG practices
- A look at the recent patents
- An analysis of the industry structure, including companies' market shares, alliances, M&A activity and venture funding outlook
- Company profiles of major players within the industry, including Lonza, Thermo Fisher Scientific Inc., WuXi AppTec, Catalent Inc., IQVIA Inc., and ICON plc
Key Attributes:
| Report Attribute | Details |
| No. of Pages | 143 |
| Forecast Period | 2023 - 2029 |
| Estimated Market Value (USD) in 2023 | $212.2 Billion |
| Forecasted Market Value (USD) by 2029 | $310.2 Billion |
| Compound Annual Growth Rate | 6.7% |
| Regions Covered | Global |
Key Topics Covered:
Chapter 1 Executive Summary
Chapter 2 Market Overview
- Outsourcing Benefits
- Outsourcing Drawbacks
- Contract Manufacturing
- Contract Manufacturing Types
- Criteria for Evaluating a Contract Manufacturer
- Core Functional Areas Requiring Constant Attention
- Common Metrics for Selecting an Outsourcing Partner for Pharmaceutical Manufacturing
- Top Sources of Dissatisfaction of Client or Contract Giver
- Contract Research
- Selecting a Contract Research Organization
- Contract Packaging
- Key Considerations When Choosing a Contract Packager
- Need of a Contract Packager
Chapter 3 Market Dynamics
- Market Drivers
- Resilient Pharmaceutical Demand
- Need for Speed to Market
- Shift to More Complex Oral Therapies
- Significant Growth in Biologics and Cell and Gene Therapy Market
- Rising Demand for Highly Potent Application Program Interfaces (HPAPI)s
- Growing Demand for Generics and Biosimilars
- Market Restraints
- Strict Regulations and Compliance Requirements
- Biotech Funding Challenges
- Persistent Geopolitical Tension and Supply Chain Risks
- Shortage of Skilled Personnel
- Market Trends
- Shift in Role of CDMOs from Service Providers to Strategic Partners
- Sustainability
- Increasing Consolidation
Chapter 4 Emerging Technologies and Developments
- Contract Manufacturing
- Increased Use of Digital Automation
- Flexible Manufacturing
- Continuous Flow Manufacturing
- Expansion of Single-Use Technologies
- Contract Research
- Innovative Trial Design
- Decentralized and Hybrid Clinical Trials
- Real World Evidence
- Increased Use of Artificial Intelligence and Machine Learning
- Functional Service Partnership Model
- Accelerating Global Rare Disease Research
- Contract Packaging
- Sustainable Packaging
- Smart Packaging
Chapter 5 Market Segmentation Analysis
- Contract Manufacturing Market by Product Type
- Drug Substances
- Drug Products
- Drug Products Market by Dosage Form Type
- Drug Product Market by Drug Delivery System Type
- Contract Manufacturing Market by Drug Molecule Type
- Small Molecule Drugs
- Biologics
- Advanced Therapies
- Contract Manufacturing Market by Region
- Contract Research Market by Functional Service Type
- Drug Discovery
- Preclinical Development
- Clinical Development
- Contract Research Market by Therapeutic Area
- Oncology
- Immunology and Inflammation
- Neurology
- Cardiovascular
- Others
- Contract Research Market by Region
- Contract Packaging Market by Service Type
- Primary Packaging
- Secondary Packaging
- Tertiary Packaging
- Geographic Breakdown
- Contract Packaging Market by Region
Chapter 6 Competitive Intelligence
- Contract Manufacturing
- Market Shares
- CMO Business Models
- Contract Research
- Market Shares
- CRO Business Models
- Contract Packaging
- Recent Mergers and Acquisition
Chapter 8 Company Profiles
- Amcor plc
- Catalent Inc.
- Charles River Laboratories
- ICON plc
- IQVIA Inc.
- Laboratory Corporation of America Holdings
- Lonza
- Pfizer Inc.
- Schott Pharma
- Thermo Fisher Scientific Inc.
- Wuxi AppTec
- WestRock Co.
For more information about this report visit https://www.researchandmarkets.com/r/9h3nd
About ResearchAndMarkets.com
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
Attachment
